Team discovers a nanodrug that attacks cancer twice

Tel Aviv University (TAU) researchers have proven that a drug delivery system based on lipid nanoparticles can utilize RNA to overcome resistance to both chemotherapy and immunotherapy in cancer treatments. The study opens a new path to a personalized and precisely targeted battle against cancer.